ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,106Medicare Part D Prescriptions Filled, Including Refills

Rank: 400 out of 2343

$651K Total Retail Price of All Prescriptions

Rank: 384 out of 2343

233 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
86% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

35% of this provider’s 233 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

9% of this provider’s 233 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

0% of this provider’s 7,625 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

31% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

48 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
IPRATROPIUM-ALBUTEROL 639 405 1 99
WARFARIN SODIUM 627 552 2 8
FAMOTIDINE 377 200 3 60
METOPROLOL TARTRATE 332 245 4 7
HEPARIN SODIUM 314 199 5 198
FUROSEMIDE 293 263 6 6
SANTYL 264 199 7 195
COMBIVENT 259 161 8 144
LEVOTHYROXINE SODIUM 241 160 9 2
POLYETHYLENE GLYCOL 3350 214 100 10 54
SERTRALINE HCL 213 143 11 20
SIMVASTATIN 212 192 12 1
FENTANYL 208 96 S2 13 69
LISINOPRIL 206 159 14 3
LEVETIRACETAM 171 92 15 104
ALBUTEROL SULFATE 160 106 16 126
GABAPENTIN 159 38 17 16
AMLODIPINE BESYLATE 148 114 18 5
METOCLOPRAMIDE HCL 146 67 19 168
LANTUS 144 97 20 51
OMEPRAZOLE 140 128 21 4
OXYCODONE-ACETAMINOPHEN 130 71 S2 22 49
LEVOFLOXACIN 127 66 23 106
POTASSIUM CHLORIDE 123 63 24 18
DONEPEZIL HCL 114 114 25 21
RISPERIDONE 113 112 26 61
PREDNISONE 109 69 27 37
CITALOPRAM HBR 108 78 28 17
VALPROIC ACID 93 45 29 261
QUETIAPINE FUMARATE 92 67 30 77
IBUPROFEN 88 47 31 75
LIDOCAINE HCL 85 16 32 378
TAMSULOSIN HCL 83 64 33 29
IPRATROPIUM BROMIDE 82 56 34 192
CARVEDILOL 82 74 34 27
BACLOFEN 78 30 36 161
PROAIR HFA 71 28 37 86
PANTOPRAZOLE SODIUM 71 64 37 22
MIRTAZAPINE 68 56 39 41
FLOVENT HFA 65 41 40 213
PIPERACILLIN-TAZOBACTAM 61 31 10 41 541
NOVOLOG 61 53 41 110
VANCOMYCIN HCL 61 38 41 348
METFORMIN HCL 60 49 44 9
PHENYTOIN 60 23 44 380
ATORVASTATIN CALCIUM 58 56 46 10
ONDANSETRON HCL 57 36 47 273
AMIODARONE HCL 56 54 48 158
CLOPIDOGREL 52 45 49 26
LACTULOSE 52 0 49 139
ZOLPIDEM TARTRATE 52 32 49 24
BUDESONIDE 51 34 52 313
MORPHINE SULFATE 50 32 S2 53 312
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 11, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.